- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 19.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 19.07M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 18.89M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $6.2M |
| Capex | Q1 2026 · Mar 31, 2025 | $648K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $25.58M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $26.72M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $35M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $35M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $73.9M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $63.34M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $75.59M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $106.05M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $126.53M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $147.43M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $229.54M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $237.89M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $240.06M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $303.02M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $277.51M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $218.37M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $212.69M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $409.07M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $404.03M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.14 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$4.62 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.14 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$4.62 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $52.04M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $53.48M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$21.83M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$87.27M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$18.63M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$87.59M |
| Revenue | Q1 2026 · Mar 31, 2026 | $85.45M |
| Revenue | Q1 2026 · Mar 31, 2025 | $89.88M |